Analysis of Clinical Outcomes in the Node-301 Trial: Etripamil Nasal Spray Relieves Symptoms and Reduces Emergency Room Interven
![Milestone Pharmaceuticals Announces New Data from Phase 3 RAPID Trial of Etripamil Nasal Spray in Patients with PSVT During Late-Breaking Session at the AHA Scientific Sessions 2022 Milestone Pharmaceuticals Announces New Data from Phase 3 RAPID Trial of Etripamil Nasal Spray in Patients with PSVT During Late-Breaking Session at the AHA Scientific Sessions 2022](https://mma.prnewswire.com/media/588856/Milestone_Pharmaceuticals_Logo.jpg?p=facebook)
Milestone Pharmaceuticals Announces New Data from Phase 3 RAPID Trial of Etripamil Nasal Spray in Patients with PSVT During Late-Breaking Session at the AHA Scientific Sessions 2022
![NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders](https://johnsonfrancis.org/professional/wp-content/uploads/2022/08/NODE-clinical-trials-of-Etripamil-nasal-spray-for-PSVT.jpg)
NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders
![PDF] Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. | Semantic Scholar PDF] Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e59479946271dcfde26e1388d548660d144f185c/5-Table1-1.png)
PDF] Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. | Semantic Scholar
![NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders](https://i.ytimg.com/vi/ynLSJuVtdWs/hqdefault.jpg)
NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders
![StudyPages - Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia StudyPages - Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia](https://yuzu-studypages-prod-east.s3.amazonaws.com/study_banners/266880-fb31b427-1754-4da8-996f-1bbad5758dfd.jpg)
StudyPages - Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia
![Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm | Journal of the American College of Cardiology Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/2ed6be31-b9e5-42c4-a72b-8ccfb97ee2c6/gr1.jpg)
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm | Journal of the American College of Cardiology
Etripamil nasal spray: an investigational agent for the rapid termination of paroxysmal supraventricular tachycardia (SVT)
![Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm | Journal of the American College of Cardiology Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/ca60a7be-7ce7-4325-b68b-b28202886df4/gr5.jpg)
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm | Journal of the American College of Cardiology
![First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology](https://www.ahajournals.org/cms/asset/79a49eac-d498-4e10-b2ae-1606b08e0411/circep.122.010915.fig01.jpg)